Eating foods rich in lycopene, like tomatoes, may help protect your blood vessels by mopping up harmful molecules that cause damage, which could keep plaque from building up in your arteries.
Claim Context
Dietary lycopene reduces oxidative stress by neutralizing reactive oxygen species, thereby mitigating endothelial damage and slowing atherosclerotic plaque progression.
“lycopine is a carotenoid that's mainly found in red and pink fruits and vegetables. So you get it in tomatoes and guava. Watermelon has a lot of lycopine, pink grapefruit, papayas. And lycopine helps because it's an incredibly powerful antioxidant. And one of the main drivers of plaque formation is oxidative stress that leads to cell damage. So lycopine can reverse that by targeting harmful reactive oxygen species.”
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
Evidence from Studies
Supporting (1)
Community contributions welcome
Lycopene and Its Antioxidant Role in the Prevention of Cardiovascular Diseases—A Critical Review
Contradicting (1)
Community contributions welcome
Does lycopene offer human LDL any protection against myeloperoxidase activity?
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Causal effect of dietary lycopene on atherosclerosis progression in humans
A double-blind, placebo-controlled RCT in 500 adults with early atherosclerosis (confirmed by carotid IMT >0.8mm), randomized to receive either 20 mg/day lycopene from tomato extract or placebo for 3 years. Primary outcome: change in carotid intima-media thickness (CIMT) via ultrasound. Secondary outcomes: plasma markers of oxidative stress (8-OHdG, MDA), endothelial function (FMD), and plaque composition via MRI. All participants maintain standardized diets and are monitored for adherence.
Long-term association between lycopene intake and atherosclerosis progression
A prospective cohort of 10,000 middle-aged adults without cardiovascular disease, followed for 10 years. Lycopene intake assessed via validated food frequency questionnaires and plasma lycopene levels measured at baseline and year 5. Outcomes: incident atherosclerotic events (MI, stroke) and serial CIMT measurements. Adjusted for confounders: smoking, BMI, statin use, other antioxidants. Subgroup analysis by baseline oxidative stress markers.
Correlation between lycopene levels and oxidative stress/endothelial markers
A cross-sectional study of 300 individuals with varying degrees of atherosclerosis (classified by coronary calcium score). Plasma lycopene, oxidative stress markers (F2-isoprostanes, ROS in leukocytes), and endothelial function (flow-mediated dilation) measured simultaneously. Controlled for diet, medication, and comorbidities. Focus on dose-response relationships between lycopene levels and each biomarker.
Mechanistic plausibility of lycopene neutralizing ROS and protecting endothelial cells
Human aortic endothelial cells exposed to oxidized LDL to induce oxidative stress. Treated with physiologically relevant concentrations of lycopene (0.1–10 µM). Measure intracellular ROS (DCFDA), nitric oxide bioavailability, adhesion molecule expression (VCAM-1, ICAM-1), and apoptosis (caspase-3). Compare to controls and known antioxidants (vitamin E). Include lycopene metabolites to assess active forms.
Effect of dietary lycopene on plaque burden and oxidative stress in vivo
ApoE-deficient mice fed a high-fat diet supplemented with 0.01% lycopene (equivalent to ~20 mg/day human dose) vs. unsupplemented control for 16 weeks. Outcomes: aortic root plaque area (Oil Red O staining), plasma and tissue oxidative stress markers (TBARS, SOD activity), endothelial nitric oxide synthase expression, and systemic inflammation (IL-6, TNF-α). Include lycopene tissue distribution analysis (liver, plasma, aorta).